Cambridge Cognition Holdings Plc (COG) is a leading health information services business based in the UK. It opened the day at 54p after a previous close of 55p. During the day the price has varied from a low of 55p to a high of 55p. The latest price was 54.5p (25 minute delay). Cambridge Cognition is listed on the London Stock Exchange (LSE) and employs 71 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Cambridge Cognition's share price has had significant positive movement.
Its last market close was 54p, which is 56.48% up on its pre-crash value of 23.5p and 227.27% up on the lowest point reached during the March crash when the shares fell as low as 16.5p.
If you had bought £1,000 worth of Cambridge Cognition shares at the start of February 2020, those shares would have been worth £669.08 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,774.56.
|52-week range||17p - 61p|
|50-day moving average||55.9118p|
|200-day moving average||46.2993p|
|Wall St. target price||175p|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||-10p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-15)||-19.85%|
|1 month (2020-12-23)||-1.80%|
|3 months (2020-10-23)||1.87%|
|6 months (2020-07-23)||41.56%|
|1 year (2020-01-23)||70.31%|
|2 years (2019-01-23)||-32.72%|
|3 years (2018-01-23)||-56.75%|
|5 years (2016-01-22)||-12.80%|
|Revenue TTM||£5.9 million|
|Gross profit TTM||£3.9 million|
|Return on assets TTM||-24.81%|
|Return on equity TTM||0%|
|Market capitalisation||£17.9 million|
TTM: trailing 12 months
We're not expecting Cambridge Cognition to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
You may also wish to consider:
Over the last 12 months, Cambridge Cognition's shares have ranged in value from as little as 17p up to 61p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Cambridge Cognition's is 1.0744. This would suggest that Cambridge Cognition's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Cambridge Cognition's beta into context you can compare it against those of similar companies.
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health solutions in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I?IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; and CANTAB Insight, a medical device that helps to determine an individual's cognitive health. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.